This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Stefan McDonough, Ph.D.
Senior Vice President, Head of Neuroscience at Atalanta Therapeutics
Speaker

Agenda Sessions

  • Silencing Gain-of-function KCNT1 Genetic Epilepsy with Divalent siRNA, A Novel Small Interfering RNA Technology, Durably Eliminates Spontaneous Seizures in a Mouse Epilepsy Model

    8:30am